CIBC Private Wealth Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $208M | Buy |
3,128,114
+220,313
| +8% | +$14.2M | 0.35% | 74 |
|
|
2025
Q3 | $196M | Buy |
2,907,801
+2,294,709
| +374% | +$182M | 0.34% | 81 |
|
|
2025
Q2 | $53.5M | Buy |
613,092
+76,025
| +14% | +$5.96M | 0.1% | 187 |
|
|
2025
Q1 | $32.6M | Buy |
537,067
+141,127
| +36% | +$11.5M | 0.07% | 201 |
|
|
2024
Q4 | $31.7M | Sell |
395,940
-179,443
| -31% | -$13.3M | 0.06% | 223 |
|
|
2024
Q3 | $38.6M | Buy |
575,383
+5,723
| +1% | +$470K | 0.07% | 209 |
|
|
2024
Q2 | $63.2M | Buy |
569,660
+95,293
| +20% | +$12M | 0.12% | 155 |
|
|
2024
Q1 | $65.4M | Buy |
474,367
+11,665
| +3% | +$1.47M | 0.13% | 148 |
|
|
2023
Q4 | $57.4M | Buy |
462,702
+453,917
| +5,167% | +$46.4M | 0.12% | 151 |
|
|
2023
Q3 | $820K | Sell |
8,785
-375,224
| -98% | -$42.3M | ﹤0.01% | 644 |
|
|
2023
Q2 | $49.3M | Buy |
384,009
+377,945
| +6,233% | +$45.7M | 0.11% | 161 |
|
|
2023
Q1 | $705K | Sell |
6,064
-22,779
| -79% | -$2.55M | ﹤0.01% | 659 |
|
|
2022
Q4 | $3.27K | Sell |
28,843
-4,856
| -14% | -$533K | ﹤0.01% | 747 |
|
|
2022
Q3 | $2.71M | Buy |
33,699
+27,435
| +438% | +$2.32M | 0.01% | 438 |
|
|
2022
Q2 | $467K | Buy |
6,264
+168
| +3% | +$15.3K | ﹤0.01% | 712 |
|
|
2022
Q1 | $780K | Sell |
6,096
-1,140
| -16% | -$125K | ﹤0.01% | 672 |
|
|
2021
Q4 | $971K | Buy |
7,236
+2,952
| +69% | +$424K | ﹤0.01% | 659 |
|
|
2021
Q3 | $586K | Sell |
4,284
-2,948
| -41% | -$372K | ﹤0.01% | 712 |
|
|
2021
Q2 | $772K | Buy |
7,232
+28
| +0.4% | +$2.69K | ﹤0.01% | 716 |
|
|
2021
Q1 | $647K | Buy |
7,204
+180
| +3% | +$16.9K | ﹤0.01% | 753 |
|
|
2020
Q4 | $649K | Sell |
7,024
-88
| -1% | -$7.86K | ﹤0.01% | 726 |
|
|
2020
Q3 | $728K | Buy |
+7,112
| New | +$743K | ﹤0.01% | 620 |
|
|
2020
Q2 | – | Sell |
-29,160
| Closed | -$1.96M | – | 649 |
|
|
2020
Q1 | $1.96M | Buy |
29,160
+22,360
| +329% | +$1.39M | 0.01% | 414 |
|
|
2019
Q4 | $372K | Sell |
6,800
-52
| -0.8% | -$2.47K | ﹤0.01% | 760 |
|
|
2019
Q3 | $256K | Buy |
+6,852
| New | +$266K | ﹤0.01% | 811 |
|
|
2018
Q3 | – | Sell |
-4,000
| Closed | -$95K | – | 1152 |
|
|
2018
Q2 | $95K | Hold |
4,000
| – | – | ﹤0.01% | 1040 |
|
|
2018
Q1 | $74K | Hold |
4,000
| – | – | ﹤0.01% | 1079 |
|
|
2017
Q4 | $57K | Buy |
+4,000
| New | +$52K | ﹤0.01% | 1146 |
|
Other funds holding DXCM
CIBC Private Wealth Group's DXCM Position: Q4 2025 in Review
CIBC Private Wealth Group increased its DexCom (DXCM) stake by 7.6% in Q4 2025, buying an estimated $14.2M and bringing the position to 3,128,114 shares worth $208M. The position accounts for 0.35% of the portfolio, ranked #74.
CIBC Private Wealth Group first reported a position in DXCM in Q4 2017 and has held it in 28 quarters since. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.
- CIBC Private Wealth Group held 3,128,114 shares of DexCom worth $208M as of Q4 2025.
- CIBC Private Wealth Group bought 220,313 DexCom shares in Q4 2025, an estimated $14.2M.
- DexCom made up 0.35% of CIBC Private Wealth Group's portfolio in Q4 2025, its #74 holding.
- CIBC Private Wealth Group first reported a position in DexCom in Q4 2017 and has held it in 28 quarters since.
- 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.